Biodegradable scaffolds are used in several medical applications such as cardiovascular, orthopedic, and neurology. Cardiovascular diseases such as cardiac failure are on the rise due to increased risk factors like diabetes, obesity, and smoking. Thus, the demand for biodegradable scaffolds to treat cardiovascular diseases is rising, driving the market growth.
Biodegradable scaffolds can be used as a replacement or temporary support for damaged tissues and organs in the body. They provide structural and mechanical support to the tissues and facilitate cellular colonization. These scaffolds degrade gradually as the body replaces them with native tissues. They offer advantages like biocompatibility, reduced risk of infection, and avoidance of secondary surgical procedures to remove non-biodegradable implants. With the growing prevalence of chronic diseases, there is an increasing need for biodegradable implants that provide tissue regeneration without requiring additional removal surgeries.
The global biodegradable scaffold market is estimated to be valued at US$ 2.31 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Biodegradable Scaffold Market Size are Medtronic Plc, Koninklijke Philips N.V., Abbott, Johnson & Johnson Service Inc., Merit Medical Systems, Inc., Stryker, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, Cerus Endovascular Limited., ASAHI INTECC USA, INC., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., iVascular, LifeHealthcare, Veiva, and Nordson MEDICAL. These players are focusing on new product launches and mergers & acquisitions to strengthen their presence in the market.
There is high potential for biodegradable scaffolds in applications like neurological tissue regeneration, orthopedic reconstruction, and wound healing. With ongoing research, these scaffolds can be developed further to mimic natural extracellular matrices and promote tissue regeneration more effectively.
The global biodegradable scaffold market players are expanding their presence across regions. Manufacturers are focusing on emerging economies in Asia Pacific and Latin America owing to improved healthcare infrastructure and rising medical tourism in these regions. Counties like India, China, Brazil offer high growth potential for biodegradable scaffold products.
Market Drivers
Rising geriatric population susceptible to chronic diseases: The global geriatric population, aged 65 years or more, is rising rapidly. Older adults are at a higher risk of developing cardiovascular diseases, neurological disorders, and orthopedic conditions. This is expected to increase the demand for biodegradable scaffolds for treatment of age-related diseases.
Technological advancements: Continuous research is underway to develop advanced biodegradable scaffolds with improved properties like tissue-specific degradation, enhanced cellular interactions, and integration with host tissues. New technologies like 3D printing and nanotechnology are helping manufacture complex scaffold structures mimicking natural extracellular matrices. This is anticipated to drive the market during the forecast period.
Market Restrains
High costs associated with scaffold development: Manufacturing biodegradable scaffolds involves expensive processes like material processing, sterilization, and clinical testing. Developing scaffolds tailored for specific tissue regeneration further increases costs. This makes biodegradable implants less affordable for common patients in price-sensitive markets.
Lack of specialized medical professionals: Complex scaffold fabrication techniques and their usage in tissue engineering procedures require extensive technical know-how. There is a shortage of specialized medical professionals trained in regenerative therapies using biodegradable scaffolds. This shortage acts as a market barrier in their widespread clinical adoption.
Segment Analysis
The biodegradable scaffold market is dominated by synthetic biodegradable scaffolds sub-segment due to advantages over natural biodegradable scaffolds. Synthetic biodegradable scaffolds have precise controllable degradation rate as per the healing of tissues which makes them suitable for various tissue engineering applications. They also have higher mechanical strength and lower chances of immunogenicity compared to natural biodegradable scaffolds.
Global Analysis
North America region holds the leading share in the global biodegradable scaffold market owing to rising prevalence of cardiovascular diseases, growing demand for minimally invasive surgeries, and presence of major players in the region. Asia Pacific region is projected to witness the highest growth during the forecast period due to increasing healthcare expenditure, growing aging population, rising incidences of chronic diseases. Additionally, improving healthcare infrastructure and growing medical tourism industry in Asia Pacific countries are also expected to boost the regional market growth.
Get more insights on Biodegradable Scaffold Market
